Lyon Street Capital, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 159 filers reported holding IMMUNOMEDICS INC in Q3 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.

Quarter-by-quarter ownership
Lyon Street Capital, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q1 2018$3,694,000
-48.8%
252,855
-43.4%
1.19%
-50.6%
Q4 2017$7,219,000
+244.3%
446,703
+197.8%
2.41%
+197.9%
Q3 2017$2,097,000150,0000.81%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders